Credible sources and modern genetic technology in personalized medicine
The rapidly increasing demand of healthcare needs and preventions methods along with newer forms of diseases being discovered each day, extensive investments have been made in researching the field of medicine to revolutionize the future of medicine. Medical practitioners are looking up to a promising future proposed by the studies being carried out in the fields of genetics. This has open doors for a new and one of its kind form of medicine, namely ‘Personalized Medicine.' As the name suggests, this type of medicine is patient specific and involves carrying out diagnosis and treatment plans that is customised to suit individual needs.
Intermountain Healthcare: Mission, Structure & Nursing
Intermountain was started as a small healthcare nonprofit organization, situated in Salt Lake City. With its well-crafted mission, a clearly stated vision, patient's oriented philosophy and a strategy to manage the organization effectively; it was soon able to manage over 32,000 employees. Helping the acute healthcare needs of Southeastern Idaho and Utah's residents, Intermountain's well-managed system of about 23 hospitals, clinics, physicians and health strategies; deliver clinically exceptional medical care and at an affordable rate.
Legal Environment in Healthcare and Administrative Responsibility
Many vectors—science, research funding, social acceptance or rejection—influence how and whether medical technology is eventually adopted into medical praxis (Hogle, et al., 2012). Undergirding the choices and changes is a shared body of ethical standards and law, the establishment of which is often not consensual or efficacious. Any emerging technology can encounter unanticipated social resistance and ethical concerns that can change the course of how medical science research progresses (Hogle, et al., 2012). Medical technology often poses questions about access to expensive innovations and considerations about race, gender, and social justice that are inseparable from the socio-economic levels of patients (Hogle, et al., 2012). In contemporary society, there are the inevitable considerations about patent issues, clinical practice, and the commercialization of medical innovations (Hogle, et al., 2012).